1. Project construction

Shandong Loncom Pharmaceutical Co., Ltd's annual output of 15,000 kg of rosuvastatin calcium production and new drug research and development base project is located inQihe Economic Development Zone, the main product of the project is rosuvastatin calcium original drug and comprehensive preparations. At present, the two phases of the construction of the two raw material medicine workshops have been completed and accepted, and received the approval of the acceptance in October 2014, the acceptance batch number is Dehuan inspection [ 2014】 No. 52. This acceptance is a partial acceptance, and the acceptance object is the comprehensive preparation workshop.

2. the completion time of the acceptance project

In October 2015, Shandong Longcom Pharmaceutical Co., Ltd. comprehensive preparation workshop carried out civil engineering, all civil engineering was completed in October 2016, and the project's supporting environmental protection facilities were constructed. On November 20, 2017, the project's supporting environmental protection facilities Completion.

3. Equipment commissioning time of acceptance project

On November 20, 2017, Shandong Langcom Pharmaceutical Co., Ltd. commissioned the pollution prevention and control facilities of the comprehensive preparation workshop, and the commissioning was completed on December 18, 2017.